Literature DB >> 10945519

Echocardiographic validation of gated SPECT ventricular function measurements.

K Nichols1, D Lefkowitz, T Faber, R Folks, D Cooke, E V Garcia, S S Yao, E G DePuey, A Rozanski.   

Abstract

UNLABELLED: Left ventricular (LV) volumes are valuable prognostic indicators in the management of coronary artery disease and traditionally have been obtained by x-ray contrast angiography or echocardiography. There now are several scintigraphic methods to compute volumes that are based on different LV modeling assumptions. Both the reasons that calculations from different nuclear techniques can disagree with one another and the relationship of these values to the more conventional echocardiographic measurements must be investigated thoroughly for calculations to be interpretable for individual patients.
METHODS: Echocardiographic volumes were determined in 33 retrospective subjects with coronary artery disease (mean age, 61 +/- 12 y; 42% men; 70% with abnormal perfusion and 58% with abnormal segmental wall motion) using the modified Simpson's rule technique applied to digitized apical 4-chamber and apical 2-chamber views of 4 averaged heartbeats. These volumes were compared with those from 3 gated SPECT methods based on Simpson's rule LV modeling similar to standard echocardiographic algorithms (SPECT EF from St. Luke's-Roosevelt Hospital) (method 1), Gaussian myocardial count profile curve fitting (QGS from Cedars-Sinai Medical Center) (method 2), and an endocardial model based on perfusion sampling and count-based thickening (Cardiac Toolbox from Emory University) (method 3).
RESULTS: By ANOVA, there were no significant differences among ejection fractions (EFs), but there were for volumes. Paired t test analysis showed volumes from methods 2 and 3 to be significantly larger than echocardiographic volumes and larger than those of method 1. Linear regression analysis comparing gated SPECT and echocardiographic volumes showed a nearly identical strong correlation (r = 0.92; P < 0.000001) for all 3 methods. Excellent correlation also was found among gated SPECT volumes from the 3 methods (r = 0.94). Bland-Altman analysis and t tests showed that method 1 volumes (70 +/- 61 mL) were the same as for echocardiography (77 +/- 55 mL), but volumes were overestimated by method 2 (105 +/- 74 mL) and method 3 (127 +/- 92 mL), particularly for larger volumes. Pearson coefficients for EFs compared with echocardiography were r = 0.82, 0.75, and 0.72 for methods 1-3, respectively. EFs correlated strongly among the 3 gated SPECT methods (r = 0.86-0.92). The Fisher z test showed no differences among these methods for any of the volume or EF linear correlation analyses.
CONCLUSION: All gated SPECT parameters correlated well with echocardiographic values. However, the gated SPECT method for which underlying assumptions most closely resembled those commonly used in echocardiography produced mean volume values closest in agreement with echocardiographic measurements.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10945519

Source DB:  PubMed          Journal:  J Nucl Med        ISSN: 0161-5505            Impact factor:   10.057


  32 in total

1.  Comparison between ECTb and QGS for assessment of left ventricular function from gated myocardial perfusion SPECT.

Authors:  Kenneth Nichols; Cesar A Santana; Russell Folks; Elizabeth Krawczynska; C David Cooke; Tracy L Faber; Steven R Bergmann; Ernest V Garcia
Journal:  J Nucl Cardiol       Date:  2002 May-Jun       Impact factor: 5.952

2.  A realistic 3-D gated cardiac phantom for quality control of gated myocardial perfusion SPET: the Amsterdam gated (AGATE) cardiac phantom.

Authors:  Jacco J N Visser; Ellinor Busemann Sokole; Hein J Verberne; Jan B A Habraken; Huybert J F van de Stadt; Joris E N Jaspers; Morgan Shehata; Paul M Heeman; Berthe L F van Eck-Smit
Journal:  Eur J Nucl Med Mol Imaging       Date:  2004-02       Impact factor: 9.236

3.  Volume measurements in nuclear medicine gated SPECT and 4D echocardiography: validation using a dynamic cardiac phantom.

Authors:  Dominique Debrun; Fabienne Thérain; Long-Dang Nguyen; Christophe P Léger; Jacco J N Visser; Ellinor Busemann-Sokole
Journal:  Int J Cardiovasc Imaging       Date:  2005 Apr-Jun       Impact factor: 2.357

Review 4.  Gated SPECT in assessment of regional and global left ventricular function: major tool of modern nuclear imaging.

Authors:  Aiden Abidov; Guido Germano; Rory Hachamovitch; Daniel S Berman
Journal:  J Nucl Cardiol       Date:  2006 Mar-Apr       Impact factor: 5.952

5.  Noninvasive modalities for the assessment of left ventricular function: all are equal but some are more equal than others.

Authors:  Tiong Keng Lim; Roxy Senior
Journal:  J Nucl Cardiol       Date:  2006-07       Impact factor: 5.952

6.  The increasing role of quantification in clinical nuclear cardiology: the Emory approach.

Authors:  Ernest V Garcia; Tracy L Faber; C David Cooke; Russell D Folks; Ji Chen; Cesar Santana
Journal:  J Nucl Cardiol       Date:  2007-07       Impact factor: 5.952

7.  Quantitation in gated perfusion SPECT imaging: the Cedars-Sinai approach.

Authors:  Guido Germano; Paul B Kavanagh; Piotr J Slomka; Serge D Van Kriekinge; Geoff Pollard; Daniel S Berman
Journal:  J Nucl Cardiol       Date:  2007-07       Impact factor: 5.952

8.  Evaluation of left ventricular volumes and ejection fraction by gated SPECT and cardiac MRI in patients with dilated cardiomyopathy.

Authors:  Feng Wang; Jian Zhang; Wei Fang; Shi-Hua Zhao; Min-Jie Lu; Zuo-Xiang He
Journal:  Eur J Nucl Med Mol Imaging       Date:  2009-04-18       Impact factor: 9.236

Review 9.  Gated SPECT in assessment of regional and global left ventricular function: an update.

Authors:  Aiden Abidov; Guido Germano; Rory Hachamovitch; Piotr Slomka; Daniel S Berman
Journal:  J Nucl Cardiol       Date:  2013-12       Impact factor: 5.952

10.  Gated SPECT: what's the ideal method to measure LVEF?

Authors:  Sum-Che Man; Ernst E van der Wall; Cees A Swenne
Journal:  Int J Cardiovasc Imaging       Date:  2008-09-02       Impact factor: 2.357

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.